Harvard Bioscience M&A Summary
Harvard Bioscience has acquired 3 companies. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
Harvard Bioscience’s largest acquisition to date was in 2018, when it acquired Data Sciences International for $70M. It’s largest disclosed sale occurred in 2018, when it sold Denville Scientific to Thomas Scientific for $20M. Harvard Bioscience has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (34%) and electrical equipment (34%).
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 2
- M&A Buy/Sell Connections 2
Unlimited Searches
